Media stories about Utah Medical Products (NASDAQ:UTMD) have been trending negative recently, AlphaOne Sentiment reports. The research firm, a subsidiary of Accern, identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. AlphaOne ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Utah Medical Products earned a media sentiment score of -0.35 on AlphaOne’s scale. AlphaOne also assigned press coverage about the medical instruments supplier an impact score of 50 out of 100, indicating that recent media coverage is somewhat likely to have an effect on the stock’s share price in the near future.

Shares of Utah Medical Products (NASDAQ:UTMD) opened at 62.05 on Friday. Utah Medical Products has a one year low of $56.30 and a one year high of $75.00. The company has a 50-day moving average of $61.28 and a 200 day moving average of $63.76. The stock has a market cap of $230.45 million, a price-to-earnings ratio of 19.27 and a beta of 0.60.

The company also recently declared a quarterly dividend, which was paid on Tuesday, April 4th. Stockholders of record on Friday, March 17th were paid a dividend of $0.265 per share. This represents a $1.06 annualized dividend and a dividend yield of 1.71%. The ex-dividend date was Wednesday, March 15th. Utah Medical Products’s dividend payout ratio (DPR) is presently 33.02%.

COPYRIGHT VIOLATION NOTICE: This story was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this story on another site, it was stolen and republished in violation of U.S. & international copyright legislation. The legal version of this story can be read at https://www.americanbankingnews.com/2017/04/21/utah-medical-products-utmd-earns-daily-media-impact-score-of-0-35.html.

This article was originally published by and is the sole property of American Banking News. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/04/21/utah-medical-products-utmd-earns-daily-media-impact-score-of-0-35.html

About Utah Medical Products

Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.

5 Day Chart for NASDAQ:UTMD

Receive News & Ratings for Utah Medical Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products Inc. and related companies with MarketBeat.com's FREE daily email newsletter.